Sanofi Genzyme Competitors and Similar CompaniesClear all
Biogen's competitors and similar companies include Amgen and Amicus Therapeutics.
 Biogen Biogen (formerly known as Biogen Idec) is a biopharmaceutical company that develops and delivers therapies for neurological and neurodegenerative diseases. |  Amgen Amgen (formerly known as Applied Molecular Genetics) is a biotechnology company that discovers, develops, manufactures, and delivers human therapeutics. |  Amicus Therapeutics Amicus Therapeutics is a biopharmaceutical company developing therapies for the treatment of rare and orphan diseases. | |
Founding Date | Founding Date 1978 | Founding Date 1980 | Founding Date 2002 |
Type | Type Public | Type Public | Type Public |
Tags | |||
Locations | Locations Cambridge, US HQ Vicente López, AR Macquarie Park, AU Wien, AT Machelen, BE São Paul, BR Toronto, CA see more | Locations Thousand Oaks, US HQ Hydra, DZ Vicente López, AR Sydney, AU Wien, AT Diegem, BE Santo Amaro, BR see more | Locations Philadelphia, US HQ Northbridge, AU Pointe Claire, CA Paris, FR München, DE Dublin, IE Milano, IT see more |
Employees | Employees 7,605 | Employees 25,200 | Employees 58415% increase |
Valuation ($) | Valuation ($) 26.7 b | Valuation ($) 170.4 b | Valuation ($) 3.4 b |
Financial | |||
Revenue (est.) | Revenue (est.) $9.9b (FY, 2025) | Revenue (est.) $36.8b (FY, 2025) | Revenue (est.) $634.2m (FY, 2025) |
Cost of goods | Cost of goods $2.4b (FY, 2025) | Cost of goods $12b (FY, 2025) | Cost of goods $72.9m (FY, 2025) |
Gross profit | Gross profit $7.5b (FY, 2025) | Gross profit $24.7b (FY, 2025) | Gross profit $561.3m (FY, 2025) |
Net income | Net income $1.3b (FY, 2025) | Net income $7.7b (FY, 2025) | Net income ($27.1m) (FY, 2025) |
Operating ⚠ | |||
Phase I Trials Products | Phase I Trials Products 4 (FY, 2024) | Phase I Trials Products 20 (FY, 2020) | Phase I Trials Products N/A |
Phase II Trials Products | Phase II Trials Products 6 (FY, 2024) | Phase II Trials Products 5 (FY, 2020) | Phase II Trials Products N/A |
Phase III Trials Products | Phase III Trials Products 11 (FY, 2024) | Phase III Trials Products 11 (FY, 2020) | Phase III Trials Products N/A |
For sources of this data, please see the company profile
View Company Profiles
Amgen
HQ
Thousand Oaks, US
Employees
25,200
Amgen (formerly known as Applied Molecular Genetics) is a biotechnology company that discovers, develops, manufactures, and delivers human therapeutics.
View companyAmicus Therapeutics
HQ
Philadelphia, US
Employees
584↑ 15% increase
Amicus Therapeutics is a biopharmaceutical company developing therapies for the treatment of rare and orphan diseases.
View company